155 related articles for article (PubMed ID: 19242128)
21. HDAC2 depletion promotes osteosarcoma's stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy.
La Noce M; Paino F; Mele L; Papaccio G; Regad T; Lombardi A; Papaccio F; Desiderio V; Tirino V
J Exp Clin Cancer Res; 2018 Dec; 37(1):296. PubMed ID: 30509303
[TBL] [Abstract][Full Text] [Related]
22. Side population cells isolated from human osteosarcoma are enriched with tumor-initiating cells.
Yang M; Yan M; Zhang R; Li J; Luo Z
Cancer Sci; 2011 Oct; 102(10):1774-81. PubMed ID: 21740477
[TBL] [Abstract][Full Text] [Related]
23. Mutant p53 gain of function can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells.
Di Fiore R; Marcatti M; Drago-Ferrante R; D'Anneo A; Giuliano M; Carlisi D; De Blasio A; Querques F; Pastore L; Tesoriere G; Vento R
Bone; 2014 Mar; 60():198-212. PubMed ID: 24373920
[TBL] [Abstract][Full Text] [Related]
24. Identification of Stem Cell Related Gene Expression from the Osteosarcoma Cell Core Side.
Lim C; Roh YH; Yoo SJ; Jeong DK; Nam KW
J Cancer Prev; 2022 Jun; 27(2):122-128. PubMed ID: 35864855
[TBL] [Abstract][Full Text] [Related]
25. Identification and gene expression profiling of tumor-initiating cells isolated from human osteosarcoma cell lines in an orthotopic mouse model.
Rainusso N; Man TK; Lau CC; Hicks J; Shen JJ; Yu A; Wang LL; Rosen JM
Cancer Biol Ther; 2011 Aug; 12(4):278-87. PubMed ID: 21617384
[TBL] [Abstract][Full Text] [Related]
26. Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors.
Santagata S; Ligon KL; Hornick JL
Am J Surg Pathol; 2007 Jun; 31(6):836-45. PubMed ID: 17527070
[TBL] [Abstract][Full Text] [Related]
27. Stem-like cells in bone sarcomas: implications for tumorigenesis.
Gibbs CP; Kukekov VG; Reith JD; Tchigrinova O; Suslov ON; Scott EW; Ghivizzani SC; Ignatova TN; Steindler DA
Neoplasia; 2005 Nov; 7(11):967-76. PubMed ID: 16331882
[TBL] [Abstract][Full Text] [Related]
28. Up-regulation of microRNA-491-5p suppresses cell proliferation and promotes apoptosis by targeting FOXP4 in human osteosarcoma.
Yin Z; Ding H; He E; Chen J; Li M
Cell Prolif; 2017 Feb; 50(1):. PubMed ID: 27704627
[TBL] [Abstract][Full Text] [Related]
29. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma.
Chiou SH; Yu CC; Huang CY; Lin SC; Liu CJ; Tsai TH; Chou SH; Chien CS; Ku HH; Lo JF
Clin Cancer Res; 2008 Jul; 14(13):4085-95. PubMed ID: 18593985
[TBL] [Abstract][Full Text] [Related]
30. Embryonic stem cell transcription factors and D2-40 (podoplanin) as diagnostic immunohistochemical markers in ovarian germ cell tumors.
Chang MC; Vargas SO; Hornick JL; Hirsch MS; Crum CP; Nucci MR
Int J Gynecol Pathol; 2009 Jul; 28(4):347-55. PubMed ID: 19483629
[TBL] [Abstract][Full Text] [Related]
31. Modeling human osteosarcoma in mice through 3AB-OS cancer stem cell xenografts.
Di Fiore R; Guercio A; Puleio R; Di Marco P; Drago-Ferrante R; D'Anneo A; De Blasio A; Carlisi D; Di Bella S; Pentimalli F; Forte IM; Giordano A; Tesoriere G; Vento R
J Cell Biochem; 2012 Nov; 113(11):3380-92. PubMed ID: 22688921
[TBL] [Abstract][Full Text] [Related]
32. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells.
Masui S; Nakatake Y; Toyooka Y; Shimosato D; Yagi R; Takahashi K; Okochi H; Okuda A; Matoba R; Sharov AA; Ko MS; Niwa H
Nat Cell Biol; 2007 Jun; 9(6):625-35. PubMed ID: 17515932
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of Oct3/4 in human breast cancer and normal tissues.
Zhao FQ; Misra Y; Li DB; Wadsworth MP; Krag D; Weaver D; Tessitore J; Li DW; Zhang G; Tian Q; Buss K
Int J Oncol; 2018 Jun; 52(6):2069-2078. PubMed ID: 29620155
[TBL] [Abstract][Full Text] [Related]
34. MiR-384 Inhibits Malignant Biological Behavior Such as Proliferation and Invasion of Osteosarcoma by Regulating IGFBP3.
Tan Y; Chen L; Li S; Hao H; Zhang D
Technol Cancer Res Treat; 2020; 19():1533033820909125. PubMed ID: 32129151
[TBL] [Abstract][Full Text] [Related]
35. Genes involved in regulation of stem cell properties: studies on their expression in a small cohort of neuroblastoma patients.
Melone MA; Giuliano M; Squillaro T; Alessio N; Casale F; Mattioli E; Cipollaro M; Giordano A; Galderisi U
Cancer Biol Ther; 2009 Jul; 8(13):1300-6. PubMed ID: 19458492
[TBL] [Abstract][Full Text] [Related]
36. Dioscin inhibits stem-cell-like properties and tumor growth of osteosarcoma through Akt/GSK3/β-catenin signaling pathway.
Liu W; Zhao Z; Wang Y; Li W; Su Q; Jia Q; Zhang J; Zhang X; Shen J; Yin J
Cell Death Dis; 2018 Mar; 9(3):343. PubMed ID: 29497056
[TBL] [Abstract][Full Text] [Related]
37. Micrometastatic Drug Screening Platform Shows Heterogeneous Response to MAP Chemotherapy in Osteosarcoma Cell Lines.
Collier CD; Wirtz EC; Knafler GJ; Morris WZ; Getty PJ; Greenfield EM
Clin Orthop Relat Res; 2018 Jul; 476(7):1400-1411. PubMed ID: 29481344
[TBL] [Abstract][Full Text] [Related]
38. Development and characterization of cancer stem cell-based tumoroids as an osteosarcoma model.
Ozturk S; Gorgun C; Gokalp S; Vatansever S; Sendemir A
Biotechnol Bioeng; 2020 Aug; 117(8):2527-2539. PubMed ID: 32391924
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of miR‑214 promotes the progression of human osteosarcoma by regulating the Wnt/β‑catenin signaling pathway.
Zhu XB; Zhang ZC; Han GS; Han JZ; Qiu DP
Mol Med Rep; 2017 Apr; 15(4):1884-1892. PubMed ID: 28260089
[TBL] [Abstract][Full Text] [Related]
40. A novel long non-coding RNA, hypoxia-inducible factor-2α promoter upstream transcript, functions as an inhibitor of osteosarcoma stem cells in vitro.
Wang Y; Yao J; Meng H; Yu Z; Wang Z; Yuan X; Chen H; Wang A
Mol Med Rep; 2015 Apr; 11(4):2534-40. PubMed ID: 25434862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
